In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein

Journal of Experimental Medicine

Volumn 214, Issue 5, 2017, Pages 1239-1248

  Deeg, Christoph M ^a   Hassan, Ebrahim ^a,b,c   Mutz, Pascal ^a   Rheinemann, Lara ^a   Götz, Veronika ^a   Magar, Linda ^a   Schilling, Mirjam ^a   Kallfass, Carsten ^a   Nürnberger, Cindy ^a,b   Soubies, Sébastien ^a   Kochs, Georg ^a   Haller, Otto ^a   Schwemmle, Martin ^a   Staeheli, Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Ain Shams University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; NUCLEOPROTEIN; VIRUS NUCLEOPROTEIN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA VIRUS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENE LOCUS; HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N7); INFLUENZA A VIRUS (H7N9); LD50; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; THOGOTO VIRUS; TRANSGENE; TRANSGENIC MOUSE; VIRUS ISOLATION; VIRUS RESISTANCE; ANIMAL; C57BL MOUSE; DISEASE RESISTANCE; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS; PATHOGENICITY;

ANIMALS; DISEASE RESISTANCE; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H7N7 SUBTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; MYXOVIRUS RESISTANCE PROTEINS; NUCLEOPROTEINS;

EID: 85021854371     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20161033     Document Type: Article

References (34)

1. Neumann, G., and Y. Kawaoka. 2015. Transmission of influenza A viruses. Virology. 479-480:234-246. http ://dx .doi .org/10 .1016/j .virol .2015 .03 .009
2. Watanabe, T., S. Watanabe, E.A. Maher, G. Neumann, and Y. Kawaoka. 2014. Pandemic potential of avian influenza A (H7N9) viruses. Trends Microbiol. 22:623-631. http ://dx .doi .org/10 .1016/j .tim .2014 .08 .008
3. Yoon, S.W., R.J. Webby, and R.G. Webster. 2014. Evolution and ecology of influenza A viruses. Curr. Top. Microbiol. Immunol. 385:359-375
4. Cauldwell, A.V., J.S. Long, O. Moncorgé, and W.S. Barclay. 2014. Viral determinants of influenza A virus host range. J. Gen. Virol. 95:1193-1210. http ://dx .doi .org/10 .1099/vir .0 .062836-0
5. Iwasaki, A., and P.S. Pillai. 2014. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14:315-328. http ://dx .doi .org/10 .1038/nri3665
6. Haller, O., P. Staeheli, M. Schwemmle, and G. Kochs. 2015. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23:154-163. http ://dx .doi .org/10 .1016/j .tim .2014 .12 .003
7. Pavlovic, J., T. Zürcher, O. Haller, and P. Staeheli. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:3370-3375
8. Ciancanelli, M.J., L. Abel, S.Y. Zhang, and J.L. Casanova. 2016. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr. Opin. Immunol. 38:109-120. http ://dx .doi .org/10 .1016/j .coi .2015 .12 .002
9. Mitchell, P.S., M. Emerman, and H.S. Malik. 2013. An evolutionary perspective on the broad antiviral specificity of MxA. Curr. Opin. Microbiol. 16:493-499. http ://dx .doi .org/10 .1016/j .mib .2013 .04 .005
10. Mitchell, P.S., C. Patzina, M. Emerman, O. Haller, H.S. Malik, and G. Kochs. 2012. Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe. 12:598-604. http ://dx .doi .org/10 .1016/j .chom .2012 .09 .005
11. Patzina, C., O. Haller, and G. Kochs. 2014. Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus. J. Biol. Chem. 289:6020-6027. http ://dx .doi .org/10 .1074/jbc .M113 .543892
12. Nigg, P.E., and J. Pavlovic. 2015. Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus. J. Biol. Chem. 290:29893-29906. http ://dx .doi .org/10 .1074/jbc .M115 .681494
13. Simon, V., N. Bloch, and N.R. Landau. 2015. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat. Immunol. 16:546-553. http ://dx .doi .org/10 .1038/ni .3156
14. Dittmann, J., S. Stertz, D. Grimm, J. Steel, A. García-Sastre, O. Haller, and G. Kochs. 2008. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J. Virol. 82:3624-3631. http ://dx .doi .org/10 .1128/JVI .01753-07
15. Zimmermann, P., B. Mänz, O. Haller, M. Schwemmle, and G. Kochs. 2011. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J. Virol. 85:8133-8140. http ://dx .doi .org/10 .1128/JVI .00712-11
16. Götz, V., L. Magar, D. Dornfeld, S. Giese, A. Pohlmann, D. Höper, B.W. Kong, D.A. Jans, M. Beer, O. Haller, and M. Schwemmle. 2016. Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Sci. Rep. 6:23138. http ://dx .doi .org/10 .1038/srep23138
17. Mänz, B., D. Dornfeld, V. Götz, R. Zell, P. Zimmermann, O. Haller, G. Kochs, and M. Schwemmle. 2013. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog. 9:e1003279. http ://dx .doi .org/10 .1371/journal .ppat .1003279
18. Pavlovic, J., H.A. Arzet, H.P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, and O. Haller. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:4506-4510
19. Staeheli, P., R. Grob, E. Meier, J.G. Sutcliffe, and O. Haller. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8:4518-4523. http ://dx .doi .org/10 .1128/MCB .8 .10 .4518
20. Staeheli, P., and O. Haller. 1985. Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol. Cell. Biol. 5:2150-2153. http ://dx .doi .org/10 .1128/MCB .5 .8 .2150
21. Israël, A. 1979. Preliminary characterization of the particles from productive and abortive infections of L cells by fowl plague virus. Ann. Microbiol. (Paris). 130B:85-100
22. Kochs, G., and O. Haller. 1999. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. USA. 96:2082-2086. http ://dx .doi .org/10 .1073/pnas .96 .5 .2082
23. Sadler, A.J., and B.R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568. http ://dx .doi .org/10 .1038/nri2314
24. Holzinger, D., C. Jorns, S. Stertz, S. Boisson-Dupuis, R. Thimme, M. Weidmann, J.L. Casanova, O. Haller, and G. Kochs. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81:7776-7785. http ://dx .doi .org/10 .1128/JVI .00546-06
25. Riegger, D., R. Hai, D. Dornfeld, B. Mänz, V. Leyva-Grado, M.T. Sánchez-Aparicio, R.A. Albrecht, P. Palese, O. Haller, M. Schwemmle, et al. 2015. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. J. Virol. 89:2241-2252. http ://dx .doi .org/10 .1128/JVI .02406-14
26. Frese, M., G. Kochs, U. Meier-Dieter, J. Siebler, and O. Haller. 1995. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69:3904-3909
27. Haller, O., M. Frese, D. Rost, P.A. Nuttall, and G. Kochs. 1995. Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 69:2596-2601
28. Thimme, R., M. Frese, G. Kochs, and O. Haller. 1995. Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Virology. 211:296-301. http ://dx .doi .org/10 .1006/viro .1995 .1404
29. Cheung, V.G., N. Nowak, W. Jang, I.R. Kirsch, S. Zhao, X.N. Chen, T.S. Furey, U.J. Kim, W.L. Kuo, M. Olivier, et al. BAC Resource Consortium. 2001. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature. 409:953-958. http ://dx .doi .org/10 .1038/35057192
30. Horisberger, M.A., and K. de Staritzky. 1987. A recombinant human interferon-alpha B/D hybrid with a broad host-range. J. Gen. Virol. 68:945-948. http ://dx .doi .org/10 .1099/0022-1317-68-3-945
31. Albanese, M., C. Bruno-Smiraglia, G. Di di Cuonzo, A. Lavagnino, and S. Srihongse. 1972. Isolation of Thogoto virus from Rhipicephalus bursa ticks in western Sicily. Acta Virol. 16:267
32. Anderson, C.R., and J. Casals. 1973. Dhori virus, a new agent isolated from Hyalomma dromedarii in India. Indian J. Med. Res. 61:1416-1420
33. Meier, E., G. Kunz, O. Haller, and H. Arnheiter. 1990. Activity of rat Mx proteins against a rhabdovirus. J. Virol. 64:6263-6269
34. Flohr, F., S. Schneider-Schaulies, O. Haller, and G. Kochs. 1999. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett. 463:24-28. http ://dx .doi .org/10 .1016/S0014-5793(99)01598-7